TITLE

Fludarabine for Chronic Lymphocytic Leukemia

AUTHOR(S)
Copur, M. Sitki; Ledakis, Peter; Muhvic, Joan
PUB. DATE
April 2001
SOURCE
New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1166
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "Fludarabine Compared With Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia," by K.R. Rai, B.L. Peterson and colleagues in the December 14, 2000 issue.
ACCESSION #
24915207

 

Related Articles

  • Tumor Lysis Syndrome after Treatment of Chronic Lymphocytic Leukemia with Cladribine. Dann, Eldad J.; Rachmilewitz, Eliezer A.; Rund, Deborah // New England Journal of Medicine;4/14/94, Vol. 330 Issue 15, p1090 

    A response by Eldad J. Dann and colleagues to a letter to the editor about their article "Tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia" in the November 18, 1993 issue is presented.

  • Chronic Lymphocytic Leukemia. Ijaz, Tahir // New England Journal of Medicine;2/15/96, Vol. 334 Issue 7, p472 

    A letter to the editor is presented in response to the article "Chronic lymphocytic leukemia," by C. Rozman and E. Montserrat in the October 19, 1995 issue.

  • Chronic Lymphocytic Leukemia. Hanzlik, Harold // New England Journal of Medicine;2/15/96, Vol. 334 Issue 7, p472 

    A letter to the editor is presented in response to the article "Chronic lymphocytic leukemia,' by C. Rozman and E. Montserrat in the October 19, 1995 issue.

  • Chronic Lymphocytic Leukemia. Rozman, Ciril; Montserrat, Emilio // New England Journal of Medicine;2/15/96, Vol. 334 Issue 7, p472 

    A reply by Ciril Rozman and Emilio Montserrat to letters to the editor about their article "Chronic lymphocytic leukemia," in the October 19, 1995 issue is presented.

  • Fludarabine for Chronic Lymphocytic Leukemia. Erman, Mustafa; Celik, Ismail; Tekuzman, Gulten // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1166 

    A letter to the editor is presented in response to the article "Fludarabine Compared With Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia," by K.R. Rai, B.L. Peterson and colleagues in the December 14, 2000 issue.

  • Fludarabine for Chronic Lymphocytic Leukemia. Marchetti, Monia; Barosi, Giovanni; Liberato, Lucio N. // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1166 

    A letter to the editor is presented in response to the article "Fludarabine Compared With Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia," by K.R. Rai, B.L. Peterson and colleagues in the December 14, 2000 issue.

  • Fludarabine for Chronic Lymphocytic Leukemia. Proctor, Stephen J.; Mounter, Philip; Summerfield, Geoffrey P. // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1166 

    A letter to the editor is presented in response to the article "Fludarabine Compared With Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia," by K.R. Rai, B.L. Peterson and colleagues in the December 14, 2000 issue.

  • Fludarabine for Chronic Lymphocytic Leukemia. Rai, Kanti R. // New England Journal of Medicine;04/12/2001, Vol. 344 Issue 15, p1166 

    A response by Kanti R. Rai to several letters to the editor about her article "Fludarabine Compared With Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia," in the December 14, 2000 issue.

  • Reply to Piccaluga et al. Laporte, J-P; Isnard, F; Fouillard, L; Garderet, L; Gorin, N-C // Leukemia (08876924);Jan2005, Vol. 19 Issue 1, p136 

    Presents a letter to the editor replying to a comment on a study on the use of alemtuzumad in an adult patient with refractory acute lymphocytic leukemia.

Share

Read the Article

Other Topics